Pharmacoeconomic Evaluations in the Treatment of Non-Small Cell Lung Cancer

Author： Carlson Josh J.   Veenstra David L.   Ramsey Scott D.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.8, 2008-01, pp. : 1105-1113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Pharmacoeconomic Review

By Coukell A.J.   Noble S.   Faulds D.  

PharmacoEconomics, Vol. 15, Iss. 4, 1999-04 ,pp. : 405-417

Adis International

Access to resources Recommend Favorite

Paclitaxel: A Pharmacoeconomic Review of its Use in Non-Small Cell Lung Cancer

By Plosker G.L.   Hurst M.  

PharmacoEconomics, Vol. 19, Iss. 11, 2001-11 ,pp. : 1111-1134

Adis International

Access to resources Recommend Favorite

Pemetrexed for the treatment of non-small cell lung cancer

By Genova Carlo  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1545-1558

Informa Healthcare

Access to resources Recommend Favorite

Vinorelbine in the Treatment of Non-Small Cell Lung Cancer

By  

Current Medicinal Chemistry, Vol. 9, Iss. 8, 2002-04 ,pp. : 879-891

Bentham Science Publishers

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite